Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699774 · ClinicalTrials.gov registry record · Phase 1
Effect of Repeated Doses of DS-8500a on Pharmacokinetics of Rosuvastatin in Healthy Volunteers
A Phase 1 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT03699774 is a Phase 1 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 24 participants.
The verdict
NCT03699774, a Phase 1 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the effect of repeated doses of DS-8500a on the single dose pharmacokinetics (PK) of rosuvastatin. The total length of time (from screening to follow-up) for each participant is approximately 7 weeks. It is expected that repeated oral doses of DS-8500a will not have a significant effect on the pharmacokinetics of a single dose of rosuvastatin.
Interventions
- DRUG Rosuvastatin
- DRUG DS-8500a
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-05-12 |
| Est. Completion | 2015-07-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03699774
The ClinicalTrials.gov registry entry for NCT03699774 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Rosuvastatin is the first listed.
NCT03699774 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03699774 about?
NCT03699774 is a clinical study titled "Effect of Repeated Doses of DS-8500a on Pharmacokinetics of Rosuvastatin in Healthy Volunteers". The primary purpose of this study is to assess the effect of repeated doses of DS-8500a on the single dose pharmacokinetics (PK) of rosuvastatin. The total length of time (from screening to follow-up) for each participant is approximately 7 weeks. It is expected that repeated oral doses of DS-8500...
What is the current status of trial NCT03699774?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2015-05-12. Estimated completion is 2015-07-06.
What interventions are being tested in trial NCT03699774?
The interventions under investigation include: Rosuvastatin (DRUG), DS-8500a (DRUG).
Who is sponsoring clinical trial NCT03699774?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.